Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization

NCT02471313 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

3

Enrollment

NIH

Sponsor class

Conditions

Liver Cancer
Liver Neoplasm
Hepatocellular Carcinoma
HCC

Interventions

DRUG: [18F] FMISO

Sponsor

National Institutes of Health Clinical Center (CC)